Literature DB >> 21557272

Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.

Markus Greiner1, Birgit Kreutzer, Sven Lang, Volker Jung, Adolfo Cavalié, Gerhard Unteregger, Richard Zimmermann, Bernd Wullich.   

Abstract

BACKGROUND: We previously reported that over-expression of the SEC62 gene is a widespread phenomenon in prostate cancer. Since the use of endoplasmic reticulum (ER) stress-inducing substances such as thapsigargin in prostate cancer therapy is widely discussed in the literature, we investigated the influence of Sec62 protein content on the cellular response to these drugs.
METHODS: Growth effects were analyzed by real-time cell analysis and viability tests in DU145-cells representing an increased SEC62 expression or PC3- and LNCaP-cells representing a similar SEC62 expression compared to non-tumor cells. Ca(2+) -imaging in an established HeLa-system with fluorescent dye was used to study molecular effects of Sec62 depletion.
RESULTS: We found a lower propensity toward apoptotic cell death after thapsigargin treatment for DU145 cells compared to PC3 or LNCaP and siRNA-mediated silencing of SEC62 resulted in a reduced viability of thapsigargin-treated PC3 cells, indicating that Sec62 functions in cellular stress response. Measurement of cytosolic [Ca(2+) ] demonstrated the influence of Sec62 on the cellular response to thapsigargin on a molecular level. Using real-time cell analysis, we observed the loss of androgen stimulation of LNCaP cells in the presence of thapsigargin, and an additional negative effect on cell growth of Sec62 depletion. Also, for PC3- and DU145-cells Sec62 depletion inhibited growth after thapsigargin treatment.
CONCLUSIONS: Our data indicate a crucial function of Sec62 in the response to thapsigargin-induced ER stress. This will be of great significance on the background of elevated Sec62 protein levels in prostate cancer cells when treatment with thapsigargin analogs is considered.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557272     DOI: 10.1002/pros.21324

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

2.  The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

Authors:  Alan P Fields; Verline Justilien; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2015-12-23

Review 3.  Components and Mechanisms of Import, Modification, Folding, and Assembly of Immunoglobulins in the Endoplasmic Reticulum.

Authors:  Richard Zimmermann
Journal:  J Clin Immunol       Date:  2016-02-29       Impact factor: 8.317

Review 4.  ER-phagy and human diseases.

Authors:  Christian A Hübner; Ivan Dikic
Journal:  Cell Death Differ       Date:  2019-10-28       Impact factor: 15.828

5.  Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation.

Authors:  Song Su; Yan-Ting Shi; Yi Chu; Ming-Zuo Jiang; Nan Wu; Bing Xu; He Zhou; Jun-Chao Lin; Yi-Rong Jin; Xiao-Fei Li; Jie Liang
Journal:  Cell Mol Life Sci       Date:  2022-02-15       Impact factor: 9.261

6.  SEC62 and SEC63 Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver Tissue.

Authors:  Markus Casper; Maximilian Linxweiler; Johannes Linxweiler; Richard Zimmermann; Matthias Glanemann; Frank Lammert; Susanne N Weber
Journal:  Visc Med       Date:  2021-01-12

Review 7.  Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex.

Authors:  Mark Sicking; Sven Lang; Florian Bochen; Andreas Roos; Joost P H Drenth; Muhammad Zakaria; Richard Zimmermann; Maximilian Linxweiler
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

8.  Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.

Authors:  Li Weng; Juan Du; Qinghui Zhou; Binbin Cheng; Jun Li; Denghai Zhang; Changquan Ling
Journal:  Mol Cancer       Date:  2012-06-08       Impact factor: 27.401

9.  Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.

Authors:  Maximilian Linxweiler; Florian Bochen; Bernhard Schick; Silke Wemmert; Basel Al Kadah; Markus Greiner; Andrea Hasenfus; Rainer-Maria Bohle; Ingolf Juhasz-Böss; Erich-Franz Solomayer; Zoltan Ferenc Takacs
Journal:  BMC Cancer       Date:  2016-08-23       Impact factor: 4.430

10.  Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.

Authors:  Maximilian Linxweiler; Stefan Schorr; Nico Schäuble; Martin Jung; Johannes Linxweiler; Frank Langer; Hans-Joachim Schäfers; Adolfo Cavalié; Richard Zimmermann; Markus Greiner
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.